Fowler P D, Dawes P T
Eur J Clin Pharmacol. 1985;27(6):689-91. doi: 10.1007/BF00547050.
'Osmosin' (sodium indomethacin trihydrate, now withdrawn) produced a constant rate of release of indomethacin into the gut. Paired plasma and synovial fluid samples were obtained at regular intervals following a single dose of 'Osmosin' (19 patients) and after continuous daily dosing (15 patients). Indomethacin is rapidly absorbed and plasma concentrations maintained in the range 0.3 to 0.6 micrograms/ml after the first 4 h. Equilibrium between plasma and synovial fluid occurs, with SF/plasma ratios 0.74 to 0.82 12-24 h after a single dose and up to 0.96 thereafter. The indomethacin synovial fluid/plasma profile is changed by Osmosin from the pattern of a short half-life drug to the pattern typical of a long half-life drug. Results from serial samples obtained by use of indwelling cannulae (in vein and knee joint) show close agreement with our single paired sampling technique. Our method may have theoretical disadvantages but it has many practical advantages.
“奥斯莫辛”(吲哚美辛三水合钠,现已退市)能使吲哚美辛在肠道中持续释放。在单次服用“奥斯莫辛”后(19例患者)以及连续每日给药后(15例患者),定期采集配对的血浆和滑液样本。吲哚美辛吸收迅速,在最初4小时后血浆浓度维持在0.3至0.6微克/毫升范围内。血浆和滑液之间达到平衡,单次给药后12至24小时,滑液/血浆比值为0.74至0.82,此后高达0.96。“奥斯莫辛”使吲哚美辛在滑液/血浆中的分布模式从半衰期短的药物模式转变为半衰期长的药物典型模式。通过留置套管针(置于静脉和膝关节)采集的系列样本结果与我们的单次配对采样技术结果密切一致。我们的方法可能在理论上存在缺点,但具有许多实际优势。